Skip to content

Studying knee surgery with an innovative technique for faster recovery

A prospective study on arthroscopic remnant sparing anterior cruciate ligament reconstruction - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086465
Enrollment
40
Registered
2025-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Remnant sparing arthroscopic anterior cruciate ligament reconstruction: Remnant sparing ACL reconstruction is a surgical technique that aims to preserve the remaining tissue of a torn a

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients undergoing arthroscopic reconstruction of anterior cruciate ligament injuries with complete anterior cruciate ligament tear on femoral side of age 18 years and above

Exclusion criteria

Exclusion criteria: Patient who have no ligament stump remaining and type 4 resorption patients with tibial sided avulsions or tibial sided ACL tear and patients with infective knee arthritis revision surgeries and regenerative arthritis of knee

Design outcomes

Primary

MeasureTime frame
It is expected to have significant clinical outcomes of Arthroscopic remnant sparing anterior cruciate ligament reconstruction and comparing the results with standard arthroscopic anterior cruciate ligament reconstructionTimepoint: Assessment will be done every 6 weeks 3 months 6 months

Secondary

MeasureTime frame
Comparison of post operative range of movement in the treated knees and knee stabilityTimepoint: Assessment will be done every 6 weeks 3 months 6 months

Countries

India

Contacts

Public ContactDr Sandeep Shrivastav

Datta Meghe Institute of Higher Education and Research Sawangi Meghe Wardha

ceohospitals@gmail.com9765404068

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026